AZD4547 is a FGFR1 inhibitor that markedly suppressed SOX2 expression and tumor growth in orthotopic and subcutaneous H1581 and DMS1144 lung cancer xenograft models [461]. This evidence concerns the gene SOX2 and neoplasm.